Felbamate in Lennox-Gastaut Syndrome

Abstract

The Felbamate Study Group report results in 73 patients ages 4 to 36 years with the Lennox-Gastaut syndrome, using a double-blind, placebo- controlled, add-on trial design.

Keywords

• lennox-gastaut syndrome
• trial design
• felbamate-treated patients